Seminars in Oncology
Volume 33, Issue 5 , Pages 614-624, October 2006

Vaccines in Renal Cell Carcinoma

  • Hubert Kübler
    • ,
  • Johannes Vieweg

      Affiliations

    • J.V. is receiving research support from Geron Corporation. He has acted as a consultant for Argos Therapeutics, Geron Corporation, Novartis Pharmaceuticals Corporation, and GlaxoSmithKline.
    • Corresponding Author InformationAddress correspondence to Johannes Vieweg, MD, Department of Urology, University of Florida, College of Medicine, Room N2-3, Health Science Center, PO Box 100247, Gainesville, FL 32610-0247, USA.

Department of Urology, University of Florida, College of Medicine, Gainesville, FL.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by grants from the National Cancer Institute (RO1 CA93910, R21 CA098446, RO1 CA89102), and the National Center for Research Resources, (MO1-RR-30), General Clinical Research Centers Program.

PII: S0093-7754(06)00277-6

doi:10.1053/j.seminoncol.2006.06.011

Seminars in Oncology
Volume 33, Issue 5 , Pages 614-624, October 2006

Article Tools